Compound 61
Identifiers
- Canonical SMILES:
CN(C)CCC[C@](O)(c1ccccc1)c1ccc(OCc2cccc(c2)-c2ccc(cc2)C(O)=O)cc1
- IUPAC name:
4-[3-[[4-[4-(dimethylamino)-1-hydroxy-1-phenylbutyl]phenoxy]methyl]phenyl]benzoic acid
- InChi:
InChI=1S/C32H33NO4/c1-33(2)21-7-20-32(36,28-10-4-3-5-11-28)29-16-18-30(19-17-29)37-23-24-8-6-9-27(22-24)25-12-14-26(15-13-25)31(34)35/h3-6,8-19,22,36H,7,20-21,23H2,1-2H3,(H,34,35)/t32-/m0/s1
- InChiKey:
WHAPPDCEEYUSOQ-YTTGMZPUSA-N
External links
52950126 |
26362571 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 5.24 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 495.24 g/mol | |||
HBA | 5 | |||
HBD | 2 | |||
HBA + HBD | 7 | |||
AlogP | 3.51 | |||
TPSA | 70.00 | |||
RB | 11 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6636 | Ansofaxine | DB15052 | |
0.5714 | Adomeglivant | DB11704 | |
0.5678 | KH064 | DB04287 | |
0.5620 | Etripamil | DB12605 | |
0.5575 | LY-2300559 | DB13016 | |
0.5566 | Adapalene | DB00210 | |
0.5431 | Fesoterodine | DB06702 | |
0.5378 | Mebeverine | DB12554 | |
0.5312 | {4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone | DB07237 | |
0.5304 | Estradiol benzoate | DB13953 | |
0.5283 | Umeclidinium | DB09076 | |
0.5278 | Dyclonine | DB00645 | |
0.5263 | 2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid | DB04405 | |
0.5258 | Terfenadine | DB00342 | |
0.5254 | Bitolterol | DB00901 |